课题基金 / 基金详情

PENCICLOVIR DURING DOSING WITH FAMCICLOVIR IN H HBEAG POSITIVE CHRONIC HEP B

PENCICLOVIR DURING DOSING WITH FAMCICLOVIR IN H HBEAG POSITIVE CHRONIC HEP B
HBEAG 阳性慢性乙肝患者中喷昔洛韦与泛昔洛韦一起给药
批准号：
6244710
负责人：
ANNA S.F. LOK
金额：
$2.22万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-02-20 至 1997-11-30
来源：
https://reporter.nih.gov/project-details/6244710
关键词：
acyclovir antiviral agents chronic disease /disorder clinical research clinical trials drug screening /evaluation hepatitis B hepatitis B antigens hepatitis B virus group human subject human therapy evaluation liver disorder chemotherapy pharmacokinetics

项目摘要

项目成果

ANNA S.F. LOK的其他基金

相似基金

相关文献

中文摘要
翻译
本研究为多中心随机对照试验的附录 泛昔洛韦治疗慢性B肝炎 的患者 已经同意参与治疗方案的患者， 被邀请参加这项可选研究，以确定 泛昔洛韦的药代动力学在慢性 肝炎
英文摘要
This study is an appendix of a multi-center randomized controlled trial of famciclovir in the treatment of chronic hepatitis B. Patients who have already consented to participation in the treatment protocol will be invited to take part in this optional study to determine if the pharmacokinetics of famciclovir is altered in patients with chronic hepatitis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION
Hepatitis B Clinical Research Network Clinical Center: Michigan-Hawaii consortium
Hepatitis B Clinical Research Network Clinical Center: Michigan-Hawaii consortium
海外基金